Candel Therapeutics, Inc. (CADL) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Candel Therapeutics, Inc. (CADL) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

CADL Income Statement

Candel Therapeutics, Inc. (CADL) annual income statement — 7-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31K	31K	31K	31K	31K	31K
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-100%	-100%	-100%	-100%	0%	0%	0%	0%	0%	-
Cost of Goods Sold	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31K	31K	31K	31K	31K	31K
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100%	100%	100%	100%	100%	100%
Gross Profit Growth %	-	-	-	-	-	-	-	-	-	-	-100%	-100%	-100%	-100%	0%	0%	0%	0%	0%	-
Operating Expenses	26.75M	16.28M	15.75M	13.21M	11.18M	8.13M	8.14M	8.76M	8.57M	7.9M	10.32M	8.86M	9.58M	9.63M	8.08M	8.91M	8.78M	9.02M	7.62M	7.93M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	26077.42%	28748.39%	28335.48%	29087.1%	24587.1%	25577.42%
Selling, General & Admin	6.95M	6.44M	4.72M	4.75M	4.19M	4.11M	3.32M	3.34M	3.59M	3.8M	3.06M	3.02M	3.65M	4.16M	3.16M	3.54M	3.76M	3.6M	3.92M	2.79M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10193.55%	11406.45%	12135.48%	11612.9%	12635.48%	9016.13%
Research & Development	19.8M	9.84M	11.03M	8.46M	6.99M	4.02M	4.82M	5.42M	4.98M	4.1M	7.26M	5.84M	5.93M	5.47M	4.97M	5.38M	5.02M	5.42M	3.85M	5.26M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16038.71%	17341.94%	16200%	17474.19%	12432.26%	16983.87%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-48K	0	0	0	-149K	-131K
Operating Income	-26.75M	-16.28M	-15.75M	-13.21M	-11.18M	-8.13M	-8.14M	-8.76M	-8.57M	-7.9M	-10.32M	-8.86M	-9.58M	-9.63M	-8.1M	-8.88M	-8.75M	-8.99M	-7.74M	-8.03M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-26132.26%	-28648.39%	-28235.48%	-28987.1%	-24967.74%	-25900%
Operating Income Growth %	-139.29%	-100.3%	-93.49%	-50.82%	-30.4%	-2.89%	21.1%	1.17%	10.52%	17.97%	-27.37%	0.23%	-9.44%	-7.2%	-4.66%	-10.61%	-65.12%	-92.96%	-26.37%	-
EBITDA	-26.43M	-16.14M	-15.59M	-13.01M	-10.94M	-7.88M	-7.9M	-8.51M	-8.32M	-7.65M	-10.07M	-8.62M	-9.34M	-9.4M	-7.88M	-8.68M	-8.57M	-8.82M	-7.56M	-8.01M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-25419.35%	-27987.1%	-27632.26%	-28454.84%	-24393.55%	-25832.26%
EBITDA Growth %	-141.66%	-104.63%	-97.43%	-52.87%	-31.4%	-3.06%	21.58%	1.21%	10.93%	18.63%	-27.78%	0.69%	-9.07%	-6.6%	-4.21%	-8.34%	-61.81%	-90.48%	-23.58%	-
D&A (Non-Cash Add-back)	320K	149K	163K	195K	242K	245K	245K	245K	249K	251K	249K	245K	236K	230K	221K	205K	187K	165K	178K	21K
EBIT	-37.33M	-7.3M	-28.08M	-11.11M	-4.56M	7.68M	-13.68M	-10.16M	-21.67M	-7.58M	-10.42M	-7.77M	-8.97M	-8.19M	-8.05M	-8.17M	-3.71M	-8.99M	1.61M	-7.9M
Net Interest Income	97K	-242K	-314K	792K	690K	628K	-100K	-251K	-327K	-326K	-258K	-167K	-191K	102K	0	-176K	-365K	-175K	-11K	-14K
Interest Income	1.67M	1.32M	1.1M	953K	926K	934K	290K	236K	240K	320K	415K	502K	453K	711K	-	343K	70K	0	0	0
Interest Expense	1.57M	1.56M	1.42M	161K	236K	306K	390K	487K	567K	646K	673K	669K	644K	609K	-	519K	435K	175K	11K	14K
Other Income/Expense	-12.16M	7.42M	-13.74M	1.94M	6.38M	15.51M	-5.93M	-1.89M	-13.67M	-319K	-777K	426K	-35K	838K	3.02M	193K	4.6M	8.11M	9.34M	-8.13M
Pretax Income	-38.91M	-8.86M	-29.5M	-11.27M	-4.8M	7.38M	-14.07M	-10.65M	-22.24M	-8.22M	-11.1M	-8.44M	-9.61M	-8.79M	-5.08M	-8.69M	-4.15M	-874K	1.6M	-16.16M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-16396.77%	-28025.81%	-13383.87%	-2819.35%	5148.39%	-52135.48%
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-38.91M	-8.86M	-29.5M	-11.27M	-4.8M	7.38M	-14.07M	-10.65M	-22.24M	-8.22M	-11.1M	-8.44M	-9.61M	-8.79M	-5.08M	-8.69M	-4.15M	-874K	1.6M	-16.16M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-16396.77%	-28025.81%	-13383.87%	-2819.35%	5148.39%	-52135.48%
Net Income Growth %	-711.2%	-220.08%	-109.59%	-5.85%	78.43%	189.76%	-26.84%	-26.21%	-131.3%	6.53%	-118.28%	2.91%	-131.72%	-906.29%	-418.48%	46.24%	75.71%	80.48%	115.23%	-
Net Income (Continuing)	-38.91M	-8.86M	-29.5M	-11.27M	-4.8M	7.38M	-14.07M	-10.65M	-22.24M	-8.22M	-11.1M	-8.44M	-9.61M	-8.79M	-5.08M	-8.69M	-4.15M	-874K	1.6M	-16.16M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.52	-0.14	-0.54	-0.21	-0.09	0.23	-0.40	-0.33	-0.74	-0.28	-0.38	-0.29	-0.33	-0.30	0.37	-0.29	0.02	0.25	0.07	-0.69
EPS Growth %	-458.54%	-160.87%	-35%	36.36%	87.42%	182.14%	-5.26%	-13.79%	-124.24%	6.67%	-202.7%	0%	-2188.61%	-220%	444.92%	57.97%	102.29%	204.17%	112.13%	-
EPS (Basic)	-0.52	-0.14	-0.54	-0.21	-0.09	0.23	-0.40	-0.33	-0.74	-0.28	-0.38	-0.29	-0.33	-0.30	0.37	-0.29	0.02	0.25	0.07	-0.69
Diluted Shares Outstanding	74.13M	62.36M	54.9M	54.89M	51.49M	31.68M	35.56M	32.01M	29.88M	29.2M	28.98M	28.92M	28.92M	28.92M	28.9M	28.89M	28.81M	28.69M	23.33M	23.33M
Basic Shares Outstanding	74.13M	62.36M	54.9M	54.89M	51.49M	31.68M	35.56M	32.01M	29.88M	29.2M	28.98M	28.92M	28.92M	28.92M	28.9M	28.89M	28.81M	28.69M	23.33M	23.33M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-